Literature DB >> 24584583

Comparison of a very low-calorie-ketogenic diet with a standard low-calorie diet in the treatment of obesity.

Basilio Moreno1, Diego Bellido, Ignacio Sajoux, Albert Goday, Dolores Saavedra, Ana B Crujeiras, Felipe F Casanueva.   

Abstract

The global prevalence of obesity has significantly increased in most industrialized countries. Anti-obesity drugs are scarce, and indications to change their life style are impractical. Therefore, to identify diets able to produce significantly and maintained weight loss is mandatory. The present work evaluated the efficacy of a very low-calorie-ketogenic (VLCK) diet in obesity. A group of obese patients were randomized into two groups: the VLCK diet group and a standard low-calorie diet (LC group). The follow-up period was 12 months. Both groups received external support, counseling, to perform physical activity and adhered to the diet. The VLCK diet induced a 30-45 days of mild ketosis and significant effects on body weight within 15 days. At 2 months, the weight reductions in the VLCK diet and LC diet groups were 13.6 ± 3.9 and 4.8 ± 2.7 kg, respectively (p < 0.0001). At the end of the study, at 12 months, the weight reductions were 19.9 ± 12.3 and 7.0 ± 5.6 kg, respectively (p < 0.0001), and more than 88 % of patients in the VLCK diet group lost more of 10 % of their initial weight. Lean mass was practically unaffected. The VLCK diet was well tolerated and the side effects were moderate and transitory. In a group of obese patients, the VLCK diet was significantly more effective than a standard LC diet. At one year follow-up in the group with VLCK diet, most of the patients loss more than 10 % of their initial weight and lean mass was well preserved.

Entities:  

Mesh:

Year:  2014        PMID: 24584583     DOI: 10.1007/s12020-014-0192-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  44 in total

1.  Anti-obesity drugs: to be or not to be?

Authors:  R V Dvorak; A M Sharma; A Astrup
Journal:  Obes Rev       Date:  2010-11-03       Impact factor: 9.213

2.  A self-regulation program for maintenance of weight loss.

Authors:  Rena R Wing; Deborah F Tate; Amy A Gorin; Hollie A Raynor; Joseph L Fava
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

3.  Effects of dietary composition on energy expenditure during weight-loss maintenance.

Authors:  Cara B Ebbeling; Janis F Swain; Henry A Feldman; William W Wong; David L Hachey; Erica Garcia-Lago; David S Ludwig
Journal:  JAMA       Date:  2012-06-27       Impact factor: 56.272

4.  Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Authors:  W Philip T James; Ian D Caterson; Walmir Coutinho; Nick Finer; Luc F Van Gaal; Aldo P Maggioni; Christian Torp-Pedersen; Arya M Sharma; Gillian M Shepherd; Richard A Rode; Cheryl L Renz
Journal:  N Engl J Med       Date:  2010-09-02       Impact factor: 91.245

5.  Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.

Authors:  Luc F Van Gaal; Aila M Rissanen; André J Scheen; Olivier Ziegler; Stephan Rössner
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

Review 6.  Prevalence of general and abdominal obesity in the adult population of Spain, 2008-2010: the ENRICA study.

Authors:  J L Gutiérrez-Fisac; P Guallar-Castillón; L M León-Muñoz; A Graciani; J R Banegas; F Rodríguez-Artalejo
Journal:  Obes Rev       Date:  2011-12-12       Impact factor: 9.213

Review 7.  Surgical treatment of type 2 diabetes: the surgeon perspective.

Authors:  Alpana P Shukla; Soo Min Ahn; Rajesh T Patel; Matthew W Rosenbaum; Francesco Rubino
Journal:  Endocrine       Date:  2011-08-13       Impact factor: 3.633

8.  Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain.

Authors:  Felipe F Casanueva; Basilio Moreno; Rosario Rodríguez-Azeredo; Christine Massien; Pedro Conthe; Xavier Formiguera; Vivencio Barrios; Beberly Balkau
Journal:  Clin Endocrinol (Oxf)       Date:  2009-10-15       Impact factor: 3.478

Review 9.  The unrelenting fall of the pharmacological treatment of obesity.

Authors:  Guido Di Dalmazi; Valentina Vicennati; Renato Pasquali; Uberto Pagotto
Journal:  Endocrine       Date:  2013-05-16       Impact factor: 3.633

10.  A double-blind randomized placebo-controlled trial of sibutramine.

Authors:  G A Bray; D H Ryan; D Gordon; S Heidingsfelder; F Cerise; K Wilson
Journal:  Obes Res       Date:  1996-05
View more
  38 in total

1.  Safety and efficacy of a multiphase dietetic protocol with meal replacements including a step with very low calorie diet.

Authors:  Sabrina Basciani; Daniela Costantini; Savina Contini; Agnese Persichetti; Mikiko Watanabe; Stefania Mariani; Carla Lubrano; Giovanni Spera; Andrea Lenzi; Lucio Gnessi
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

2.  Lifestyle Modification Group for Lymphedema and Obesity Results in Significant Health Outcomes.

Authors:  Leslyn Keith; Carol Rowsemitt; Lorie G Richards
Journal:  Am J Lifestyle Med       Date:  2017-11-21

3.  Efficacy and safety of very low calorie ketogenic diet (VLCKD) in patients with overweight and obesity: A systematic review and meta-analysis.

Authors:  Marco Castellana; Eleonora Conte; Angelo Cignarelli; Sebastio Perrini; Andrea Giustina; Luca Giovanella; Francesco Giorgino; Pierpaolo Trimboli
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

4.  Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress?

Authors:  A B Crujeiras; D Gomez-Arbelaez; M A Zulet; M C Carreira; I Sajoux; D de Luis; A I Castro; J Baltar; I Baamonde; A Sueiro; M Macias-Gonzalez; D Bellido; F J Tinahones; J A Martinez; F F Casanueva
Journal:  Int J Obes (Lond)       Date:  2017-06-07       Impact factor: 5.095

5.  Effectiveness, Compliance, and Acceptability of Preoperative Weight Loss with a Liquid Very Low-Calorie Diet Before Bariatric Surgery in Real Practice.

Authors:  Kamthorn Yolsuriyanwong; Komdej Thanavachirasin; Kimberly Sasso; Lauren Zuro; Jessica Bartfield; Eric Marcotte; Bipan Chand
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

6.  Obesity treatment by very low-calorie-ketogenic diet at two years: reduction in visceral fat and on the burden of disease.

Authors:  Basilio Moreno; Ana B Crujeiras; Diego Bellido; Ignacio Sajoux; Felipe F Casanueva
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

7.  Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial.

Authors:  Lingli Cai; Jun Yin; Xiaojing Ma; Yifei Mo; Cheng Li; Wei Lu; Yuqian Bao; Jian Zhou; Weiping Jia
Journal:  Front Med       Date:  2021-06-29       Impact factor: 4.592

8.  Effect of DHA supplementation in a very low-calorie ketogenic diet in the treatment of obesity: a randomized clinical trial.

Authors:  Daniel de Luis; Joan Carles Domingo; Olatz Izaola; Felipe F Casanueva; Diego Bellido; Ignacio Sajoux
Journal:  Endocrine       Date:  2016-04-27       Impact factor: 3.633

9.  Ketogenesis activates metabolically protective γδ T cells in visceral adipose tissue.

Authors:  Emily L Goldberg; Irina Shchukina; Jennifer L Asher; Sviatoslav Sidorov; Maxim N Artyomov; Vishwa Deep Dixit
Journal:  Nat Metab       Date:  2020-01-20

10.  The Contribution of Foods Prepared Outside the Home to the Diets of 18- to 30-Year-Old Australians: The MYMeals Study.

Authors:  Lyndal Wellard-Cole; Alyse Davies; Juliana Chen; Jisu Jung; Kim B Bente; Judy Kay; Wendy L Watson; Clare Hughes; Anna Rangan; Kalina Yacef; Irena Koprinska; Kathy Chapman; Nim Ting Wong; Luke Gemming; Cliona Ni Mhurchu; Adrian Bauman; Margaret Allman-Farinelli
Journal:  Nutrients       Date:  2021-05-21       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.